CN1857275A - 一种用于治疗阴道疾病的药物组合物 - Google Patents
一种用于治疗阴道疾病的药物组合物 Download PDFInfo
- Publication number
- CN1857275A CN1857275A CN 200610072090 CN200610072090A CN1857275A CN 1857275 A CN1857275 A CN 1857275A CN 200610072090 CN200610072090 CN 200610072090 CN 200610072090 A CN200610072090 A CN 200610072090A CN 1857275 A CN1857275 A CN 1857275A
- Authority
- CN
- China
- Prior art keywords
- tinidazole
- promestriene
- pharmaceutical composition
- described pharmaceutical
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 27
- 239000003814 drug Substances 0.000 title abstract description 17
- 208000013464 vaginal disease Diseases 0.000 title abstract description 6
- 229940079593 drug Drugs 0.000 title description 6
- 229960005053 tinidazole Drugs 0.000 claims abstract description 56
- HJLSLZFTEKNLFI-UHFFFAOYSA-N Tinidazole Chemical compound CCS(=O)(=O)CCN1C(C)=NC=C1[N+]([O-])=O HJLSLZFTEKNLFI-UHFFFAOYSA-N 0.000 claims abstract description 54
- IUWKNLFTJBHTSD-AANPDWTMSA-N promestriene Chemical compound C1C[C@]2(C)[C@@H](OC)CC[C@H]2[C@@H]2CCC3=CC(OCCC)=CC=C3[C@H]21 IUWKNLFTJBHTSD-AANPDWTMSA-N 0.000 claims abstract description 48
- 229960004765 promestriene Drugs 0.000 claims abstract description 48
- 210000001215 vagina Anatomy 0.000 claims abstract description 19
- 239000000829 suppository Substances 0.000 claims abstract description 15
- 239000003826 tablet Substances 0.000 claims abstract description 5
- 239000002775 capsule Substances 0.000 claims abstract description 4
- 239000008194 pharmaceutical composition Substances 0.000 claims description 25
- 229920000858 Cyclodextrin Polymers 0.000 claims description 9
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical group O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 claims description 9
- 239000000463 material Substances 0.000 claims description 7
- -1 hydroxypropyl Chemical group 0.000 claims description 6
- 241001597008 Nomeidae Species 0.000 claims description 5
- 239000002552 dosage form Substances 0.000 claims description 5
- 125000001301 ethoxy group Chemical group [H]C([H])([H])C([H])([H])O* 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 abstract description 13
- 238000012360 testing method Methods 0.000 description 21
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 10
- 239000003960 organic solvent Substances 0.000 description 9
- 241000283973 Oryctolagus cuniculus Species 0.000 description 8
- 208000024891 symptom Diseases 0.000 description 8
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 7
- 241001465754 Metazoa Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 6
- 230000002159 abnormal effect Effects 0.000 description 6
- 238000013270 controlled release Methods 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 230000003203 everyday effect Effects 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 239000013642 negative control Substances 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 230000000844 anti-bacterial effect Effects 0.000 description 5
- 206010020565 Hyperaemia Diseases 0.000 description 4
- 206010046914 Vaginal infection Diseases 0.000 description 4
- 206010047799 Vulvovaginitis trichomonal Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 206010013786 Dry skin Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 239000005662 Paraffin oil Substances 0.000 description 3
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 3
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 3
- 201000008100 Vaginitis Diseases 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 230000004927 fusion Effects 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000011837 pasties Nutrition 0.000 description 3
- 239000000546 pharmaceutical excipient Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 230000002354 daily effect Effects 0.000 description 2
- 230000013872 defecation Effects 0.000 description 2
- 230000000857 drug effect Effects 0.000 description 2
- 230000003628 erosive effect Effects 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000007794 irritation Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 231100000915 pathological change Toxicity 0.000 description 2
- 230000036285 pathological change Effects 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 150000004958 5-nitroimidazoles Chemical class 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000606125 Bacteroides Species 0.000 description 1
- 241000606124 Bacteroides fragilis Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- 241000224432 Entamoeba histolytica Species 0.000 description 1
- 206010015719 Exsanguination Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- 241000191992 Peptostreptococcus Species 0.000 description 1
- 241000605862 Porphyromonas gingivalis Species 0.000 description 1
- 206010039793 Seborrhoeic dermatitis Diseases 0.000 description 1
- 208000031737 Tissue Adhesions Diseases 0.000 description 1
- 208000027709 Vulvovaginal disease Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 230000002547 anomalous effect Effects 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 230000001595 contractor effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940007078 entamoeba histolytica Drugs 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 210000004392 genitalia Anatomy 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000010562 histological examination Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 239000003978 infusion fluid Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- SRQKTCXJCCHINN-NYYWCZLTSA-N nifuratel Chemical compound O=C1OC(CSC)CN1\N=C\C1=CC=C([N+]([O-])=O)O1 SRQKTCXJCCHINN-NYYWCZLTSA-N 0.000 description 1
- 229960002136 nifuratel Drugs 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 231100000255 pathogenic effect Toxicity 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000003285 pharmacodynamic effect Effects 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 239000002423 protozoacide Substances 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 210000004994 reproductive system Anatomy 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000008742 seborrheic dermatitis Diseases 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 230000036269 ulceration Effects 0.000 description 1
- 239000006216 vaginal suppository Substances 0.000 description 1
- 229940120293 vaginal suppository Drugs 0.000 description 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
例数 | 痊愈 | 有效 | 无效 | 总有效率 | |||||
例数 | 痊愈率 | 例数 | 有效率 | 例数 | 无效率 | ||||
滴虫性阴道炎 | 试验组A | 20 | 18 | 90% | 2 | 10% | 0 | 0% | 100% |
对照组B | 20 | 15 | 75% | 4 | 20% | 1 | 5% | 95% | |
对照组C | 20 | 14 | 70% | 4 | 20% | 2 | 10% | 90% |
例数 | 痊愈 | 有效 | 无效 | 总有效率 | |||||
例数 | 痊愈率 | 例数 | 有效率 | 例数 | 无效率 | ||||
细菌性阴道炎 | 试验组A | 20 | 17 | 85% | 3 | 15% | 0 | 0% | 100% |
对照组B | 20 | 14 | 70% | 5 | 25% | 1 | 5% | 95% | |
对照组C | 20 | 12 | 60% | 6 | 30% | 2 | 10% | 90% |
Claims (14)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100720900A CN100522176C (zh) | 2006-04-10 | 2006-04-10 | 一种用于治疗阴道疾病的药物组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100720900A CN100522176C (zh) | 2006-04-10 | 2006-04-10 | 一种用于治疗阴道疾病的药物组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1857275A true CN1857275A (zh) | 2006-11-08 |
CN100522176C CN100522176C (zh) | 2009-08-05 |
Family
ID=37296263
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100720900A Expired - Fee Related CN100522176C (zh) | 2006-04-10 | 2006-04-10 | 一种用于治疗阴道疾病的药物组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100522176C (zh) |
-
2006
- 2006-04-10 CN CNB2006100720900A patent/CN100522176C/zh not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CN100522176C (zh) | 2009-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8586549B2 (en) | Composition and method for modulating and maintaining vaginal bacterial flora and vaginal acidity | |
CN101843614B (zh) | 甲硝哒唑或其药学上可接受的衍生物的用途 | |
CN101744833B (zh) | 一种治疗细菌性阴道炎的药物组合物 | |
MXPA03010022A (es) | Composicion que comprende agentes antifungicos para tratar vulvovaginitis y vaginosis. | |
CN108635585A (zh) | 一种治疗老年性阴道炎的药物组合物及温敏缓释凝胶剂和制备方法 | |
CN1903289A (zh) | 治疗痔类肛肠疾病的凝胶剂及制备方法 | |
CN102038679B (zh) | 一种双唑泰阴道凝胶及其制备方法 | |
CN101229126A (zh) | 一种替硝唑复合纳米银微乳抗菌药物 | |
CN100394919C (zh) | 一种用于治疗阴道疾病的药物组合物 | |
CN100408041C (zh) | 一种治疗外阴和/或阴道感染疾病的药物组合物 | |
RU2632110C2 (ru) | Способ лечения или профилактики бактериального вагиноза | |
CN102526056B (zh) | 一种伏立康唑滴耳液及其制备方法和用途 | |
KR101653424B1 (ko) | 성전염성 감염 치료에 사용하기 위한 약학적 조성물 | |
CN101912376B (zh) | 双层结构的苦参碱阴道泡腾片及制备方法 | |
CN100522176C (zh) | 一种用于治疗阴道疾病的药物组合物 | |
CN101933895A (zh) | 硝酸芬替康唑的阴道栓剂组合物 | |
CN1304002C (zh) | 塞克硝唑阴道泡腾片及其生产方法 | |
CN100402037C (zh) | 一种治疗外阴和/或阴道疾病的药物组合物 | |
CN105362289A (zh) | 一种阴道滞留硼酸制剂及其制备方法 | |
CN1063632C (zh) | 一种治疗皮肤病的外用搽剂 | |
CN1771989A (zh) | 一种治疗妇科炎症的复方制剂 | |
CN103127490A (zh) | 一种治疗外阴阴道念珠菌病的药物组合物 | |
RU2375064C1 (ru) | Фармацевтическая композиция для лечения заболеваний урогенитальных органов | |
CN100340263C (zh) | 一种用于治疗细菌性阴道炎的栓剂及其制备方法 | |
CN101147740A (zh) | 阴道用药物组合物及其制备 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Assignee: BEIJING LANEVA PHARMACEUTICAL CO.,LTD. Assignor: Yang Jun Contract record no.: 2012990000455 Denomination of invention: Medicinal composition for treating vagina disease Granted publication date: 20090805 License type: Exclusive License Open date: 20061108 Record date: 20120629 |
|
ASS | Succession or assignment of patent right |
Owner name: BEIJING LANEVA PHARMACEUTICAL CO., LTD. Free format text: FORMER OWNER: YANG JUN Effective date: 20150313 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100020 CHAOYANG, BEIJING TO: 100024 CHAOYANG, BEIJING |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150313 Address after: 100024 No. 559 Shuangqiao Village, Guan Zhuang Town, Beijing, Chaoyang District Patentee after: BEIJING LANEVA PHARMACEUTICAL CO.,LTD. Address before: 100020, No. 903, building 1302, nine district, Chaoyang District, Beijing, Jinsong Patentee before: Yang Jun |
|
CP03 | Change of name, title or address | ||
CP03 | Change of name, title or address |
Address after: 101300 No.9 Mintai Road, Beiwu Town, Shunyi District, Beijing Patentee after: Beijing Jincheng Taier Pharmaceutical Co.,Ltd. Address before: 100024 No. 559, shuangqiaoli, Guanzhuang Township, Chaoyang District, Beijing Patentee before: BEIJING LANEVA PHARMACEUTICAL Co.,Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090805 |